"The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSS"...
Topicort® (desoximetasone) Ointment USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
DOSAGE AND ADMINISTRATION
Apply a thin film of Topicort® (desoximetasone) Ointment USP, 0.05% to the affected skin areas twice daily. Rub in gently.
Topicort® (desoximetasone) Ointment USP, 0.05% is supplied in:
15 gram tubes (NDC 51672-5263-1), and 60 gram tubes (NDC 51672-5263-3).
Store at controlled room temperature between 20 to 25°C (68 to 77°F), excursions permitted to 15 to 30°C (59 to 86°F). [See USP Controlled Room Temperature]
Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1. Dist. by: TaroPharma a division of Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. Revised: May, 2010This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 6/14/2010
Additional Topicort Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.